ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 274

Participation in the Stanford University Chronic Pain Self-Management Program in a Population with a High Prevalence of Arthritis

Dina Jones1, Louise Murphy 2, Ranjita Misra 1, Alison Vargovich 3, Dana Guglielmo 4, Maura Robinson 1, Samantha Shawley-Brzoska 1, Sijin Wen 1, Megan Burkart 1 and Richard Vaglienti 1, 1West Virginia University, Morgantown, WV, 2Centers for Disease Control and Prevention, Division of Population Health, Atlanta, 3University at Buffalo - SUNY, Buffalo, NY, 4Centers for Disease Control and Prevention, Division of Population Health, Atlanta, GA

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: arthritis management and community programs, Chronic pain, opioids, Self-management

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 10, 2019

Title: Health Services Research Poster I – ACR/ARP

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: In 2016, 1 in 5 US adults reported chronic pain (CP). Osteoarthritis and rheumatoid arthritis are top causes of CP. The Stanford University Chronic Pain Self-Management Program (CPSMP) is a 6-week, low-cost community-delivered workshop that increases participants’ confidence in self-managing their CP. We describe baseline participation in a randomized, wait-list (6 months) controlled trial on CPSMP’s short- and longer-term outcomes in West Virginia, a population with a high prevalence of arthritis, CP, opioid deaths, and socio-economic deprivation.

Methods: Community-dwelling adults, aged ≥ 18, with CP of ≥ 3 months, were eligible. Ineligibility criteria were cancer, an open wound, planned surgery in next year, or participation in a similar self-management program in the past year. Participants were recruited from clinics and the community via direct mailings, newspaper articles/advertisements, word-of-mouth, social media, and an electronic patient portal. Baseline data collected included age, sex, arthritis status (yes/no), and pain severity (Stanford Pain Visual Numeric Scale [0=no pain, 10=severe pain]), categorized as no (0), low (1-4), moderate (5-6), or severe (7-10) pain. Participation was the number enrolled divided by the number of eligible participants, multiplied by 100. Barriers to enrollment were identified. Descriptive statistics determined the characteristics of those who enrolled in the study. Statistical tests were conducted to determine if pain severity (categories) varied by: 1) age (Spearman’s correlation) or 2) sex and arthritis (Cochran-Mantel-Haenszel tests).

Results: From June 2018 to March 2019, 336 people inquired about the study, 323 (96%) were screened for eligibility, 281 of the 323 (87%) were eligible, and 176 of the 281 enrolled, for a total of 63% participation. Enrollment barriers to participation were: not understanding what CP meant, the stigma associated with having CP, low socioeconomic status, and competing life priorities. At baseline, participants were primarily women (76%); mean age ± SD was 65 ± 13 years (range, 28 to 88). Most participants had arthritis (88%). The mean ± SD, range, and median (interquartile range) pain severity scores were 6.6 ± 1.9, 0-10, and 7.0 (3.0), respectively, with 1% with no pain, 10% mild pain, 39% moderate pain, and 50% with severe pain. Among those with severe pain (n=86), 71% were women and 89% had arthritis. The prevalence of severe pain was lower among older participants (43%, aged ≥ 65) compared to younger ones (61%, aged 18-64) (p=0.006). The distribution of pain severity was similar by sex (p=0.23) or arthritis status (p=0.66).

Conclusion: In a population with multiple challenges, including high arthritis prevalence, participation seemed moderate, possibly due to barriers identified during recruitment. One in 2 trial participants reported severe pain indicating that the recruitment strategy captured individuals in West Virginia with a substantial need for pain management interventions. Because some barriers to trial participation may also be barriers to implementing CPSMP in the community, strategies to increase understanding of CP and reduce its stigma may be important ways to eventually increase CPSMP’s reach.


Disclosure: D. Jones, None; L. Murphy, None; R. Misra, None; A. Vargovich, None; D. Guglielmo, None; M. Robinson, None; S. Shawley-Brzoska, None; S. Wen, None; M. Burkart, None; R. Vaglienti, None.

To cite this abstract in AMA style:

Jones D, Murphy L, Misra R, Vargovich A, Guglielmo D, Robinson M, Shawley-Brzoska S, Wen S, Burkart M, Vaglienti R. Participation in the Stanford University Chronic Pain Self-Management Program in a Population with a High Prevalence of Arthritis [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/participation-in-the-stanford-university-chronic-pain-self-management-program-in-a-population-with-a-high-prevalence-of-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/participation-in-the-stanford-university-chronic-pain-self-management-program-in-a-population-with-a-high-prevalence-of-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology